Taiwan FDA registration 210728ea564524c3cde8608ac9000df0
Gold quasi-palladium blood glucose testing system
TW: 金準鈀金血糖測試系統
Taiwan·Risk Class 2·Yinwu Biopharmaceutical Co., Ltd.;; Taiwan Luhua Technology Co., Ltd·Registered Feb 12, 2019 – Sep 13, 2028ActiveRegistration details
- Analysis ID
- 210728ea564524c3cde8608ac9000df0
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PD BIOMEDICAL CO., LTD.
Product details
- Intended Use
- This product provides diabetic patients with home measurement of blood glucose value, which can measure the microvascular whole blood collected through the fingertip and the microvascular blood glucose value of the arm before ectopic blood collection.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 委託製造;; QMS/QSD;; 國產
Dates and status
- Registration Date
- Feb 12, 2019
- Expiry Date
- Sep 13, 2028
About this record
Access comprehensive regulatory information for Gold quasi-palladium blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 210728ea564524c3cde8608ac9000df0 and manufactured by Yinwu Biopharmaceutical Co., Ltd.;; Taiwan Luhua Technology Co., Ltd. The authorized representative in Taiwan is PD BIOMEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices